European Pharmaceutical Review
2,113 FOLLOWERS
European Pharmaceutical Review is the leading bi-monthly publication for information on technologies in drug discovery and manufacturing. News, articles, whitepapers & webinars covering Genetics, Chromatography, Spectroscopy, Microbiology, Drug Manufacturing, Biomarkers, Molecular Imaging, PCR
European Pharmaceutical Review
12h ago
The research highlights a potential approach to address cross-contamination challenges during cell-processing operations.
The post Optimal biosafety cabinet cleaning strategy proposed appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
3d ago
The proposed technique outperformed traditional controllers, supporting improved air quality control in cleanrooms, according to the study.
The post Innovating intelligent cleanroom control systems appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
4d ago
The anti-amyloid drug study highlights the importance of longer-term follow-up to determine benefits and risks of dementia treatments.
The post Drug for rare form of Alzheimer’s “scientifically promising” appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
5d ago
EPR Issue 1 includes articles on manufacturing, drug delivery, process analytical technology (PAT), RNA therapeutics and more.
The post <em>European Pharmaceutical Review</em> Issue 1 2025 appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
6d ago
The new data shows potential of the psilocybin treatment to provide durable, longer-term antidepressant effects in patients with treatment-resistant depression (TRD).
The post Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
1w ago
The company now has ABPI membership after a two-year suspension involving concerns relating to its compliance with the industry body’s code of conduct.
The post Novo Nordisk industry membership reinstated appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
1w ago
The company’s new acquisition, valued up to $1 billion, supports development of in vivo cancer treatments and the future of cell therapy.
The post AstraZeneca cell therapy acquisition to advance <em> in vivo </em> therapies appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
1w ago
The throughput achieved by the researchers exceeded that of other reported methods by orders of magnitude, supporting the advancement of precision nanomaterials.
The post Nanomaterial research potential “game-changer” for drug delivery appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
1w ago
The European marketing authorisation offers a new treatment option for patients with transfusion-dependent anaemia in lower-risk myelodysplastic syndromes (LR-MDS), who are unresponsive to erythropoiesis-stimulating agents.
The post European Commission approves Rytelo for LR- MDS-related anaemia appeared first on European Pharmaceutical Review ..read more
European Pharmaceutical Review
1w ago
Approximately 1,000 eligible NHS patients could benefit from the new endometriosis treatment annually.
The post NICE recommends innovative endometriosis pill appeared first on European Pharmaceutical Review ..read more